- Home
- Down Syndrome Market

Global Down Syndrome Market - Industry Trends and Forecast to 2028
- Published Date: September, 2022 | Report ID: CLS-73 | No of pages: 377 | Format:
Global Down syndrome market is projected to register a CAGR of 14.2% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028.
Market Segmentation:
Global Down Syndrome Market, By Disease Type (Trisomy 21, Translocation Down Syndrome, Mosaic Down Syndrome), Treatment (Diagnosis, Therapy), End User (Hospital, Clinics, Homecare Setting, Therapy Centers, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Turkey, Lithuania, Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Saudi Arabia, UAE, Israel, Kuwait, Egypt, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Some of the major factors contributing to the growth of global Down syndrome market are:
Rising awareness about the disease
Increasing government support
Market Players:
The key market players for global Down syndrome market are listed below:
Natera, Inc.
Next Biosciences
AtilaBiosystems
Myriad Genetics, Inc.
PerkinElmer Inc.
F. Hoffmann-La Roche Ltd
Demeditec Diagnostics GmbH
Thermo Fisher Scientific Inc.
Abnova Corporation
Novus Biologicals (a subsidiary of Bio-Techne)
Mayo Clinic Health System
Boys Town National Research Hospital
Boston Children's Hospital
Kid Sense Child Development Corporation Pty Ltd
Down Syndrome Cork , a branch of Down Syndrome Ireland
Children's Hospital Colorado
ASDclinic.co.uk, Symbol
Abbott
Physio.co.uk.
Illumina, Inc.
TABLE OF CONTENT
Segmentation
Short Description
Global Down Syndrome Market, Down syndrome Market, By Disease Type (Trisomy 21, Translocation Down Syndrome, Mosaic Down Syndrome), Treatment (Diagnosis, Therapy), End User (Hospital, Clinics, Homecare Setting, Therapy Centers, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country(U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Poland, Switzerland, Netherlands, Hungary, Austria, Norway, Ireland, Turkey, Lithuania, Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, South Africa, Saudi Arabia, UAE, Israel, Kuwait, Egypt, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Definition:
Down syndrome is a genetic disease happens due to abnormal cell division. The abnormal cell division causes a gain of extra full or partial copy of chromosome number 21. The presence of extra genetic material causes the physical and developmental changes among the people leading to Down syndrome. The most common genetic abnormality associated with Down syndrome includes mental disabilities majorly learning disabilities in the children.
Market Segmentation:
The Down syndrome market is segmented on the basis of disease type, treatment, end user and distribution channel.
On the basis of disease type, the Down syndrome market is segmented into trisomy 21, translocation Down syndrome and mosaic Down syndrome
On the basis of treatment, the Down syndrome market is segmented into diagnosis and therapy
On the basis of end user, the Down syndrome market is segmented into hospital, clinics, homecare setting, therapy centers and others
On the basis of distribution channel, the Down syndrome market is segmented into direct tender, retail sales and others
Market Players
The key market players for global Down syndrome market are listed below:
Natera, Inc.
Next Biosciences
AtilaBiosystems
Myriad Genetics, Inc.
PerkinElmer Inc.
F. Hoffmann-La Roche Ltd
Demeditec Diagnostics GmbH
Thermo Fisher Scientific Inc.
Abnova Corporation
Novus Biologicals (a subsidiary of Bio-Techne)
Mayo Clinic Health System
Boys Town National Research Hospital
Boston Children's Hospital
Kid Sense Child Development Corporation Pty Ltd
Down Syndrome Cork , a branch of Down Syndrome Ireland
Children's Hospital Colorado
ASDclinic.co.uk, Symbol
Abbott
Physio.co.uk.
Illumina, Inc.
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.